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Abstract
Background: Patient-Centered Medical Home (PCMH) adoption is an important strategy to help improve primary
care quality within Health Resources and Service Administration (HRSA) community health centers (CHC), but
evidence of its effect thus far remains mixed. A limitation of previous evaluations has been the inability to account
for the proportion of CHC delivery sites that are designated medical homes.
Methods: Retrospective cross-sectional study using HRSA Uniform Data System (UDS) and certification files from
the National Committee for Quality Assurance (NCQA) and the Joint Commission (JC). Datasets were linked through
geocoding and an approximate string-matching algorithm. Predicted probability scores were regressed onto 11
clinical performance measures using 10% increments in site-level designation using beta logistic regression.
Results: The geocoding and approximate string-matching algorithm identified 2615 of the 6851 (41.8%) delivery sites
included in the analyses as having been designated through the NCQA and/or JC. In total, 74.7% (n = 777) of the 1039
CHCs that met the inclusion criteria for the analysis managed at least one NCQA- and/or JC-designated site. A
proportional increase in site-level designation showed a positive association with adherence scores for the
majority of all indicators, but primarily among CHCs that designated at least 50% of its delivery sites. Once this
threshold was achieved, there was a stepwise percentage point increase in adherence scores, ranging from 1.9
to 11.8% improvement, depending on the measure.
Conclusion: Geocoding and approximate string-matching techniques offer a more reliable and nuanced
approach for monitoring the association between site-level PCMH designation and clinical performance within
HRSA’s CHC delivery sites. Our findings suggest that transformation does in fact matter, but that it may not
appear until half of the delivery sites become designated. There also appears to be a continued stepwise
increase in adherence scores once this threshold is achieved.
Keywords: Health Resources and Services Administration, Community Health centers, Medical home, Geographic mapping
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Background
One of the primary tenets of the Affordable Care Act
(ACA) was to reform health care delivery through funding for patient-centered care. Its impact on primary care
has been far-reaching, particularly the ACA-related
patient-centered medical home (PCMH) initiative [1–3].
The underlying intent of PCMH-modeled care was to
transform a fragmented primary care system historically
oriented toward volume over value into a patientcentered, comprehensive, coordinated, and accessible
health care delivery model that is committed to quality
and safety [4–7]. Over the last decade, both the public
and private payers have experimented with various
PCMH payment approaches and incentives of various
kinds that link how much physicians are paid to how
well they perform on dimensions of cost or quality [8].
Despite substantial growth in the number medical
homes [9, 10], overall reviews of practice transformation
continue to yield inconsistent findings [4, 11–13]. Many
see the driving force behind variation in PCMH outcomes as stemming from differences in their design and
implementation [13]. For example, some homes may
choose to focus on better care coordination, others may
prioritize improved patient tracking, whereas others may
emphasize access. Nor are all medical homes equal.
Their processes and outcomes are influenced by the
practice size, location (e.g., urban versus rural), patient
mix, years of recognition, as well as ownership [13–17].
Variation in PCMH implementation has similarly been
found within Health Resources and Service Administration (HRSA) community health center (CHC) evaluations [18–24]. CHCs are funded through HRSA to
provide primary care services to over 23 million persons,
the vast majority of whom are among the country’s most
socially and geographically vulnerable [25]. As of 2018,
three quarters of HRSA’s 1352 CHCs were designated
medical home practices (i.e., accredited/certified), making HRSA one of the foremost adopters of medical
home-modeled care throughout the country [26].
A well-known critique unique to HRSA’s PCMH evaluations is that it is not possible to determine the degree
in which its transition is impacting performance [18, 27].
At issue is that HRSA reports its PCMH clinical performance scores at the CHC level, but a CHC’s performance is based on data submitted from its delivery sites. A
single CHC can oversee dozens of delivery sites, many
or potentially the majority of which may not be designated medical homes. Moreover, in most cases, services
delivered by the grantee (i.e., CHC) that become part of
its performance report are provided on-site at one of its
service delivery locations [28]. Similar limitations emerged
from the 2006 and 2009 Commonwealth Fund surveys of
CHC providers [23, 24]. Besides lack of currency, the
Commonwealth surveys perpetuate limitations of ecological
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fallacy because PCMH designation was defined as a CHC
that managed ‘at least one’ certified site. Both limitations
are problematic for determining whether delivery sites that
choose to embrace PCMH principles and apply for designation, or those that choose not to seek it, matters. In particular, factors associated with the designation of a single clinic
may not be associated with clinical care across all delivery
sites. The lack of differentiation between site-level designation versus organizational-level recognition is seen as a potential reason for the lack of consistency linking PCMH
designation to improvements in clinical performance [18].
The purpose of this study was to examine whether the
proportion of designated delivery sites within a CHC’s
network is associated with improved clinical performance scores. Our aim was to determine whether there
was a stepwise increase in performance as the proportion of a CHCs designated delivery sites increased. To
our understanding, this is the first attempt to address a
long-standing concern as to the use of CHC-level data
to capture the true extent that PCMH principles have
been implemented. Accordingly, this study sets out to
answer the following research question: is there a positive association between clinical performance and
PCMH status as the proportion of a CHC’s designated
delivery sites increases? To answer this question, we developed a sustainable and transparent approach for using
geocoding and approximate string-matching algorithms
to merge PCMH site-level designation data with the
HRSA uniform data system (i.e., UDS) clinical reports
and analyze the association between clinical quality and
PCMH designation using publicly available data.

Methods
CHC and delivery site spatial data

All CHC and its delivery site spatial and attribute data
were obtained through HRSA’s ArcGIS server connection (https://gisportal.hrsa.gov/server/rest/). Delivery site
identifiers were determined from the ‘Primary Health
Care Facility’ spatial layer. All CHCs were identified
from its attribute table. Specific queries using variations
of the search terms ‘dental’ and ‘eye’ and ‘urgent care’
were run in order to assess whether delivery sites other
than primary care practices were identified. No positive
matches were found. We excluded all Alaskan, Hawaiian, and other overseas delivery sites due to spatial data
that we had available for geocoding. We also excluded
clinics designated as mobile units, seasonal facilities, and
those designated only to migrant populations. Mobile
sites were excluded as they are not restricted to a serving
a particular location. Seasonal and migrant facilities were
excluded as they often have different funding parameters
than other delivery sites. These exclusions reduced the
number of potentially eligible CHCs from 1457 to 1387
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and the number of potentially eligible delivery sites from
12,549 to 8670.
PCMH identification

HRSA contracts with the Accreditation Association for
Ambulatory Health Care (AAAHC), the Joint Commission (JC), and the National Committee for Quality
Assurance (NCQA) to provide technical assistance and
training for CHCs that elect to begin the PCMH designation processes. We limited our analysis to delivery
sites that had obtained recognition through the NCQA
and/or JC as both organizations require site-level certification. We excluded the AAAHC-designated sites from
the analysis as it uses a network accreditation process,
which would bias both the evaluation of the geocoding
methodology as well as our objective to monitor an incremental increase from designation status on changes
in quality measure scores. The NCQA is the predominant accrediting body through which CHCs seek certification. As this study was limited to publicly available
reports, NCQA recognition was defined using its July
2018 roster whereas JC-accredited sites were identified
from its April 2018 report. We use the term ‘designated’
medical home throughout the remainder of this paper to
refer to a site that met the accreditation/certification requirements to obtain PCMH status.
Data linkages and address mapping

Our initial linkage employed a composite geocoding
methodology. We linked address information (e.g., street
name, street suffix, ZIP code) listed in the UDS, NCQA,
and the JC to street centerline data using the ESRI Street
Map Premium Address File, which is an enhanced version of commercial street reference data from HERE,
TomTom, and INCREMENT P. Prior to geocoding, we
standardized each address file to US Postal Service mailing format to increase the likelihood of matching the
provider address information with the street centerline
file. Standardization was done using ZP4 address correction software.
At issue, however, is that HRSA, NCQA, and JC all
use different legal and shorthand naming and address
conventions to refer to identical facilities (e.g., MedLink
Gainesville vs. MedLink, Inc. - Gainesville). We developed an approximate string algorithm using SQL in
order to avoid dropping joins that would otherwise fail
due to naming inconsistencies. Three different conditions were written in order to link delivery sites. All conditions required a name similarity tolerance. Condition 1
required an exact match on the street, city, state, and
with a name similarity tolerance value greater than 0.30
(range 0.0–1.0). Condition 2 required an exact match for
the street and state and name similarity tolerance, but
allowed the city name to have a less than perfect match.
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Condition 3 required a perfect match on the city and
state, a less than perfect match on the street, an exact
match on the street name suffix (e.g., Suite #), and an
address similarity of 0.90. All algorithms required an
exact match on ZIP code. Over 90% of all linkages were
obtained using the matching Condition 1. Our name
similarity tolerance of 0.30 was derived from manual observation of data linkages and by examining the match
information in every 20th record.
HRSA clinical performance measures

All quality measures were abstracted from HRSA’s 2018
UDS national clinical quality reports [29]. The UDS releases clinical, cost, patient, and programmatic requirement data for each CHC on an annual basis. Variations
of these clinical end points are also routinely collected
by the NCQA through its Healthcare Effectiveness Data
and Information Set (HEDIS) program [30]. Clinical
measures were grouped into 3 types: perinatal health,
preventive health screening and services, and chronic
disease management, including: (1) access to prenatal
care during the first trimester, (2) low birth weight, (3)
cervical cancer screening, (4) weight assessment and
counseling for nutrition and physical activity for children
and adolescents, (5) weight assessment and counseling
for nutrition and physical activity for adults, (6) colorectal cancer screening, (7) childhood immunizations, (8)
use of appropriate medications for asthma, (9) coronary
artery disease (CAD) lipid therapy, (10) ischemic vascular disease (IVD) use of aspirin or another antithrombotic, and (11) controlling high blood pressure among
hypertensive patients with blood pressure < 140/90).
Covariates

We used patient demographic and facility characteristics
released in the UDS to identify potential control variables. Patient characteristics included child, adult, and
elderly adult age distributions; the percent minority; living below the poverty line; insurance type; and comorbidity measured using hypertension and diabetes
rates. Institution characteristics included urban clinic location, total costs per patient, total number of delivery
sites, and average patient size.
Analysis

We used a beta logistic regression model using maximum likelihood estimation to predict the adjusted effects of an increase in site-level PCMH designation on
changes to a CHC’s clinical performance scores. A logit
link was used to ensure that the confidence intervals for
the predicted mean were between the bounds of (0,1).
To avoid data loss, we amended less than 1% of the clinical performance scores to fall between the proportions
of 0 and 1. Based on the premise that PCMH
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designation should improve overall patient care, we hypothesized that an increase in the number of designated
sites would positively correlate with an increase in a
CHC’s adherence rates for each process and outcome
measure, presuming similarities in design with respect to
the clinical, demographic, and geographic conditions
previously found to confound this association [14–17].
Additional contrasts were conducted to assess whether
discrete changes (i.e., 10%) in the proportion of a CHC’s
designated sites resulted in a stepwise increase in its adherence scores. As the data reported by HRSA are
already published as percentages, this allowed us to
model percentage point differences in clinical performance against discrete increases in PCMH saturation. In
this manner, the difference in adherence rates by percentile group can be assessed against specific designation
targets (e.g., designating 50% of all sites) that policy
makers might use.
All marginal effects were contrasted against the predicted probability scores among CHCs that had no designated delivery sites. Patient and clinical characteristics
with statistically significant (p < 0.20) differences across
PCMH saturation groups were included as covariates in
the regression models. All models were adjusted for the
number of delivery sites that each CHC managed. We
excluded all false positive and negative matches from the
regression models in order to minimize the likelihood of
inflating/deflating comparisons owing to errors in the
geocoding algorithm. We determined whether the geocoding algorithm resulted in a false positive/negative
match at the CHC level by contrasting the list of identified sites against HRSA’s PCMH recognition initiative
database [26]. If a CHC was not listed on HRSA’s
PCMH recognition database then the match was determined to be inaccurate. Point estimates for sensitivity,
specificity, false positive probability, and false negative
probability were identified using cross tabulation and
Chi-Square tests. All statistical analyses were conducted
using SAS, version 9.4 for Windows.

Results
Table 1 and shows the total number of CHCs and the
proportion of delivery sites included in the analysis prior
to the removal of false positive/negative matches. In
total, the data initially consisted of 1239 CHCs overseeing 8095 delivery sites that were identified through linkages with UDS clinical and demographic data. The
Table 1 Accuracy of the geocoding and approximate stringmatching algorithm
HRSA PCMH file
(yes, PCMH)

HRSA PCMH file
(no, PCMH)

Geocoding method (yes, PCMH)

755

38

Geocoding method (no, PCMH)

204

242
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geocoding and string-matching algorithm resulted in
755 true positive and 242 true negative CHC matches, in
addition to 38 false positive and 204 false negative
matches, for an overall accuracy rate of 80%, with a positive predictive value of 79% and a negative predictive
value of 86%. We had to exclude 42 of the 1281 records
from the sensitivity analysis because the CHC listed in
HRSA’s recognition initiative file was not listed in its
UDS database. False negative rates were less than 10%
within 22 states and the District of Columbia, and under
20% within 38 states overall. Two states, Oregon and
Minnesota, accounted for 39 of the 204 (19%) false positive matches and an 87% drop rate due to naming/address discrepancies between the NCQA/JC and the UDS
databases. These limitations could not be fixed using the
approximate string-matching algorithm.
Overall, the matching algorithm identified 2615 of the
6851 (41.8%) delivery sites included in the final analyses
as having been designated through the NCQA and/or
JC. There were 157 (6.0%) delivery sites that received
both NCQA and JC recognition. In total, 74.7% (n = 777)
of the 1039 CHCs included in the analysis after removing false positive/negative matches managed at least one
NCQA- and/or JC-designated site. This is slightly less
than the 77% HRSA published for the same year for the
lower 48 states and District of Columbia [31].
Differences in patient and clinical site characteristics
among CHCs that did and did not manage at least one
designated delivery site are shown in Table 2. CHCs that
managed at least one designated site oversaw more sites
(7.4 vs 4.3, p < 0.0001), a higher average patient load (27,
212 vs. 11,329, p < 0.0001), as well as more sites in urban
areas (40.8% vs 31.0%, p 0.006) on average than CHCs
that did not manage at least one designated site. CHCs
without a designated delivery site treated a higher proportions of adult patients (66.5% vs 61.2%, p < 0.0001) as
well as different case mixes with respect to uninsured
patients (28.2 vs 23.0, p < 0.0001) and Medicaid/CHIP
(40.2% vs. 44.8%) on average.
Table 3 displays mean adherence scores for the perinatal, preventative, and chronic disease management
measures as well as the proportion of CHCs that met or
exceeded its performance target. With the exception of
low birth weight and childhood immunization indicators,
CHCs that managed at least one designated site had statistically significantly higher performance clinical performance scores, on average. When stratified by HRSA
clinical targets for each measure, CHCs with designated
delivery sites similarly outperformed non-designated
sites on the same nine measures. On average, adherence
targets for perinatal measures were more often met
among non-PCMH CHCs, but were 11 to 14% higher
among CHCs that managed designated sites for the preventative chronic disease indicators..
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Table 2 Patient and institutional characteristics within CHCs by PCMH designation status
PCMH designation status
No designated Sites

With designated sites

p value

Mean number of delivery sites (SD)

4.3 (4.2)

7.4 (7.0)

< 0.0001

Urban

82 (31.0)

317 (40.8)

0.006

Total average patients (SD)

11,329 (13,047)

27,212 (29,720)

< 0.0001

Total costs per patient ($)

1006 (746)

1048 (591)

0.970

Children (under age 18)

23.6

28.3

< 0.0001

Adult (18–64)

66.5

61.2

< 0.0001

Older adults (age 65 and over)

10.5

10.0

0.267

Minority

56.2

54.9

0.582

Below 200% poverty line

90.1

89.6

0.527

Uninsured

28.2

23.0

< 0.0001

Medicaid/CHIP

40.2

44.8

0.001

Patient and facility characteristics
CHC characteristics

Patient case mix characteristics

Medicare

11.6

11.5

0.742

Hypertensive

28.8

29.3

0.478

Diabetic

15.7

15.5

0.601

All values in the table are percentages, unless noted with a ‘(SD)’ or ‘$’

Table 3 HRSA clinical performance measure scores among CHCs with and without at least one designated delivery site
Percentage score

No. of CHCs that met/exceeded benchmark (%)

No designated With designated p value No designated
sites
sites
sites

With designated
sites

p value

Access to prenatal care (≥ 88.1%)a

61.1

68.0

0.001

22 (8.4)

107 (13.8)

0.023

Low birth weight (≤ 6.8%)a

10.1

9.0

0.119

154 (58.8)

362 (46.6)

< 0.0001

Cervical cancer screening (≥ 55.7%)

45.3

53.5

< 0.0001 70 (26.7)

370 (47.6)

< 0.0001

Weight assessment & counseling (children)
(≥ 65.9%)

56.1

67.1

< 0.0001 110 (42.0)

444 (57.1)

< 0.0001

Weight assessment & counseling (adults)
(≥ 63.9%)

63.9

70.0

0.000

486 (62.6)

0.017

Colorectal cancer screening (≥ 42.0%)

35.8

43.6

< 0.0001 89 (34.0)

405 (52.1)

< 0.0001

32.2

34.7

0.145

14 (1.8)

0.001

72.8

83.2

< 0.0001 109 (41.6)

442 (56.9)

< 0.0001

Coronary artery disease: lipid therapy (≥ 80.7%) 73.1

80.4

< 0.0001 129 (49.2)

451 (58.0)

0.013

IVD: use of aspirin or another antithrombotic
(≥ 79.3%)

72.3

81.0

< 0.0001 125 (47.7)

506 (65.1)

< 0.0001

Controlling high blood pressure (hypertensive) 58.9
(≥ 61.2%)a

63.2

< 0.0001 119 (45.4)

466 (60.0)

< 0.0001

Perinatal health

Preventive health screening & services

a

Childhood immunization status (≥ 80%)

142 (54.2)

15 (5.7)

Chronic disease management
Use of appropriate medications for asthma
(≥ 86.6%)

a
Indicates a Healthy People 2020 Benchmark
Note: HRSA performance benchmarks are shown in parentheses
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We next examined adjusted odds ratios for each continuous dependent clinical performance score, a continuous independent variable of the proportion of designated
delivery sites, and other covariates that were statistically
significant across PCMH designation categories (see
Table 4). Odds ratios less than 1 for the low birth weight
indicator represent desirable effects. After adjustment for
patient and clinical covariates, a one-unit change PCMH
proportion increased the log odds among eight of the 11
performance measures, ranging from a 13% odds increase
(OR 1.13; 95% CI 1.02–1.24) in lipid therapy adherence to
a 39% odds increase (OR 1.39, 95% CI 1.23–1.57) in adherence scores for weight assessment and therapy treatment among children. Differences in odds for both
prenatal indicators as well as childhood immunization adherence were mixed after adjusting for designation status.
Adjusted marginal effects for discrete increases in sitelevel designation in 10% intervals are shown in Table 5.
All changes in effects are measured as percentage point
increases. All comparisons (p < 0.05) are in reference to
CHCs that had no designated delivery sites. There were
no statistically significant increases in mean predicted
probability scores for the prenatal indicators as the proportion of designated medical homes increased. The predicted probability scores for access to prenatal care
ranged from 58.1 to 59.0% across all intervals whereas
low birth weight scores ranged from 9.6 to 9.2%. Among
the preventative health and screening services measures,
the strongest indicator of a proportional effect of PCMH
designation was for childhood weight assessment and
counseling. CHCs that designated at least 20% of its
delivery sites showed a statistically significant 3.5% percentage point increase in mean predicted probability
scores, rising from 57.6 to 61.2%. These changes rose
stepwise to a 11.8 percentage point increase once a CHC
designated at least 90% of its delivery sites. With the
exception of childhood immunization scores, all other
preventative health and screening scores showed that
CHCs that designated at least half of its delivery sites
saw statistically significant increases in mean adherence
scores, ranging from a 3.0 percentage point increase in
colorectal cancer screening rates to 6.7 percentage point
increase in weight assessment and screening among
adults.
Chronic disease measures similarly showed that CHCs
improved performance after half of its delivery sites had
been designated. The exception to these trends were
IVD scores, which began generating improved adherence
scores once at least 30% of its sites became designated.
The largest change in adherence scores was for the
asthma medication adherence. Its mean scores rose from
70.7 to 74.2%, a 3.5 percentage point change, to 76.5%, a
5.8 percentage point change, as the proportion of
designated sites increased. Other indicators showed
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improvements in adherence scores across PCMH saturation groups ranging from a 2.2 percentage point
increase in hypertensive adherence scores to a 4.8 percentage point increase among the ischemic vascular
disease indicator. Counts of the number of CHCs and
delivery sites that were included in each discrete category are shown in Table 6.

Discussion
Medical homes are emerging as the standard for care
quality and comprehensive primary care delivery across
the country. As of 2018, three quarters of HRSA’s CHCs
were designated medical home sites, making HRSA one
of the country’s foremost adopters of PCMH-modeled
care. Although PCMH transformation has come to represent a “whole-person approach” to primary care delivery, [32, 33] and with numerous examples of improving
primary care delivery and lowering overall health care
costs, [34–38] there is still an emergent focus on
whether it is able to resolve differences in primary care
experiences due to racial, socioeconomic, and geographic contexts [39]. Amplifying this limitation are data
restrictions that prohibit generating risk-adjusted evaluations of medical home initiatives. These constraints similarly problematize parallel efforts to understand the
effectiveness of other initiatives to improve access and
quality of primary care [40].
Previous studies have found inconsistent evidence of
improved processes and outcomes of care since HRSA
began transitioning its CHCs into designated medical
homes. One explanation for mixed findings has been the
lack of information on the proportion of its delivery sites
that are designated medical homes. The Commonwealth
Fund Survey, though robust in context, furthers these
assumptions through dichotomizing CHCs into a singular classification of designation. What researchers are left
with is a binary indicator of PCMH status that does not
consider that the vast majority of a CHC’s delivery sites
may not be designated. A strength of this study was the
ability to use data linkage techniques to measure the association between site-level designation and changes in
performance scores. Although site-level data would help
answer questions as to the underlying drivers of improved
performance under PCMH designation (e.g., access and
communication, patient tracking, care management, etc.),
in absence of publicly available site-level clinical performance data, the proposed methodology offers an alternative
approach to monitoring the association between PCMH
designation and changes in care quality using publicly
available data.
The study findings add a new perspective as to why
using network-level designation reports to infer the extent of site-level PCMH saturation may generate mixed
results. Although we found that PCMH designation, on

1.00 (0.69–1.46)

0.77 (0.54–1.11)

1.29 (1.20–1.38)*

No insurance

Average number
of patients

* p < 0.05

1.01 (0.69–1.47)

1.24 (0.88–1.75)

Medicaid/CHIP

1.49 (0.94–2.36)

1.13 (1.05–1.22)*

1.11 (0.99–1.23)

1.19 (0.76–1.86)

1.06 (0.96–1.18)

0.99 (0.99–1.00)

% child case mix

0.99 (0.98–1.00)

Number of
delivery sites

0.96 (0.82–1.12)

Low birth
weight

Urban

1.02 (0.88–1.19)

Proportion of
designated
delivery sites

Access to
prenatal
care

1.18 (1.13–1.23)*

1.23 (0.99–1.52)

1.33 (1.08–1.65)

1.04 (0.97–1.10)

1.25 (0.95–1.63)

0.99 (0.98–0.99)

1.16 (1.06–1.26)*

Cervical cancer
screening

1.26 (0.94–1.69)
1.09 (1.03–1.15)*

1.01 (0.96–1.07)

1.28 (0.98–1.68)

1.08 (0.82–1.42)

0.95 (0.87–1.03)

1.29 (0.96–1.73)

1.32 (0.93–1.87)

0.94 (0.87–1.03)

1.00 (1.00–1.01)

1.20 (1.07–1.35)*

Weight assessment
& counseling
(adults)

2.16 (1.50–3.11)*

1.00 (0.99–1.01)

1.39 (1.23–1.57)*

Weight
assessment
& counseling
(children)

0.67 (0.52–0.86)

0.67 (0.52–0.86)

0.67 (0.52–0.86)*

1.01 (0.93–1.09)

1.12 (0.81–1.56)

0.99 (0.98–1.00)

1.22 (1.10–1.36)*

Colorectal
cancer
screening

1.30 (1.21–1.40)*

1.18 (0.81–1.72)

1.05 (0.72–1.53)

1.14 (1.03–1.27)*

1.81 (1.14–2.87)*

0.99 (0.98–1.00)

1.01 (0.86–1.18)

Childhood
immunization
status

1.21 (1.15–1.28)*

0.88 (0.67–1.16)

0.97 (0.74–1.28)

1.04 (0.96–1.12)

1.03 (0.73–1.47)

0.99 (0.98–1.00)

1.18 (1.05–1.33)*

Appropriate
medications
for asthma

Table 4 Multiple regression association between PCMH saturation within CHC delivery sites and HRSA clinical performance scores

1.21 (1.16–1.27)*

0.98 (0.79–1.23)

0.89 (0.70–1.12)

1.03 (0.96–1.10)

0.66 (0.48–0.89)*

0.99 (0.98–0.99)*

1.13 (1.02–1.24)*

Coronary artery
disease: lipid
therapy

1.11 (1.07–1.16)*

0.68 (0.55–0.84)*

0.72 (0.58–0.89)*

1.02 (0.96–1.09)

1.20 (0.91–1.59)

1.00 (0.99–1.00)

1.15 (1.05–1.26)*

IVD: use of
aspirin or
another
antithrombotic

1.06 (1.03–1.10)*

0.63 (0.53–0.74)*

0.90 (0.76–1.06)

0.98 (0.93–1.03)

0.91 (0.74–1.13)

0.99 (0.99–1.00)

1.11 (1.03–1.19)*

Controlling
high blood
pressure
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0.093 (− 0.003)

0.093 (− 0.003)

0.589 (+ 0.007)

81–90%

0.092 (− 0.004)

0.590 (+ 0.008)

91–100%

0.723 0.727 (+ 0.004) 0.731 (+ 0.008) 0.735 (+ 0.012)

0.740 0.745 (+ 0.005) 0.750 (+ 0.010) 0.755 (+ 0.015)

0.598 0.602 (+ 0.004) 0.605 (+ 0.007) 0.609 (+ 0.011)

Coronary artery disease:
lipid therapy

IVD: use of aspirin or
another antithrombotic

Controlling high blood
pressure (hypertensive)

* p < 0.05

0.707 0.713 (+ 0.006) 0.719 (+ 0.012) 0.725 (+ 0.018)

Use of appropriate
medications for asthma

Chronic disease management

0.744 (+ 0.021)

0.737 (+ 0.030)

0.339 (+ 0.001)

0.340 (+ 0.002)

0.340 (+ 0.002)

0.340 (+ 0.002)

0.748 (+ 0.025)* 0.752 (+ 0.029)* 0.756 (+ 0.033)* 0.760 (+ 0.037)* 0.764 (+ 0.041)*

0.742 (+ 0.035)* 0.748 (+ 0.041)* 0.754 (+ 0.047)* 0.759 (+ 0.052)* 0.765 (+ 0.058)*

0.339 (+ 0.001)

0.423 (+ 0.031)* 0.430 (+ 0.038)* 0.436 (+ 0.044)* 0.443 (+ 0.051)* 0.449 (+ 0.057)* 0.456 (+ 0.064)*
0.339 (+ 0.001)

0.613 (+ 0.015)

0.616 (+ 0.018)* 0.620 (+ 0.022)* 0.624 (+ 0.026)* 0.628 (+ 0.030)* 0.631 (+ 0.033)* 0.635 (+ 0.037)*

0.759 (+ 0.019)* 0.764 (+ 0.024)* 0.769 (+ 0.029)* 0.774 (+ 0.034)* 0.778 (+ 0.038)* 0.783 (+ 0.043)* 0.788 (+ 0.048)*

0.740 (+ 0.017)

0.731 (+ 0.024)

0.417 (+ 0.025)
0.339 (+ 0.001)

Childhood immunization
status

0.338 0.338 (+ 0.000) 0.338 (+ 0.000) 0.339 (+ 0.001)

Colorectal cancer screening 0.392 0.399 (+ 0.007) 0.405 (+ 0.013) 0.411 (+ 0.019)

0.680 (+ 0.034)* 0.686 (+ 0.040)* 0.693 (+ 0.047)* 0.700 (+ 0.054)* 0.706 (+ 0.060)* 0.713 (+ 0.067)*

0.673 (+ 0.027)

0.646 0.653 (+ 0.007) 0.659 (+ 0.013) 0.666 (+ 0.020)

Weight assessment &
counseling (adults)

0.523 (+ 0.030)* 0.528 (+ 0.035)* 0.533 (+ 0.040)* 0.538 (+ 0.045)* 0.543 (+ 0.050)*

0.093 (− 0.003)

0.588 (+ 0.007)

71–80%

0.576 0.588 (+ 0.012) 0.600 (+ 0.024) 0.612 (+ 0.035)* 0.623 (+ 0.047)* 0.635 (+ 0.059)* 0.647 (+ 0.071)* 0.659 (+ 0.083)* 0.671 (+ 0.095)* 0.683 (+ 0.106)* 0.694 (+ 0.118)*

0.518 (+ 0.025)

0.094 (− 0.002)

0.587 (+ 0.006)

61–70%

Weight assessment &
counseling (children)

0.513 (+ 0.020)

0.094 (− 0.002)

0.586 (+ 0.005)

51–60%

0.492 0.498 (+ 0.005) 0.503 (+ 0.010) 0.508 (+ 0.015)

0.095 (−0.001)

0.586 (+ 0.004)

41–50%

Cervical cancer screening

Preventive health screening & services

0.094 (− 0.001)

31–40%

0.096 0.096 (+ 0.000) 0.095 (−0.001)

31–30%

Low birth weight

11–20%

0.585 (+ 0.003)

1–10%

0.581 0.582 (+ 0.001) 0.583 (+ 0.002) 0.584 (+ 0.002)

0%*

Access to prenatal care

Perinatal health

Table 5 Change in marginal effects (percentage points) by discrete increases in the proportion of designated delivery sites
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Table 6 Counts of CHCs and delivery sites by increase in sitelevel PCMH designation
Proportion of
designated sites

No. of CHCs

No. of delivery sites
(designated)

0%

262

1135 (0)

1–10%

25

417 (29)

11–20%

68

630 (100)

21–30%

70

645 (173)

31–40%

116

910 (321)

41–50%

172

1062 (501)

51–60%

50

513 (295)

61–70%

72

578 (378)

71–80%

61

433 (327)

81–90%

29

242 (207)

91–100%

114

286 (284)

average, remains a positive predicator on clinical performance, the regression models suggest that previous
evidence may have been driven by CHCs that designated
at least half of its delivery sites. Although our choice to
use 10% increments to measure this effect was userspecified, the findings raise new questions pertaining to
importance of site-level saturation as well as a potential
threshold for when designation leads to better performance. Our findings also provide some initial evidence
that once CHCs designate half of their delivery sites they
could continue to expect to see a stepwise increase in
performance as they approach 100% designation. While
many of these increases were in the range of 2 to 3 percentage points, some comparisons showed a 5 to 11 percentage point increase in performance. These findings
help to confirm that transformation does in fact matter,
but it may be more nuanced then what has previously
been reported. These findings are especially important
given the inherent challenges that the full overhaul of
CHC practice culture requires [41].
At the same time, our findings also suggest a potential
ceiling effect of using PCMH status as a universal measure of care quality. If these adherence rates suggest that
delivery sites are already working at near-optimum performance (i.e., a clinic’s adherence rate cannot get any
higher), then it may become necessary to add riskadjustment criteria to annual performance reports, much
like how the Centers for Medicare and Medicaid Services do for its Hospital Readmissions Reduction Program (HRRP). At the same time, the relatively small
improvements in adherence scores across the intervals
may also reflect the fact that CHCs have historically emphasized cultural competence, teamwork, and patientcentrism, all of which may confound evaluations of its
transformation [42]. The varying effect and differences
in magnitude of PCMH designation highlight a need to
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continue examining their effect more closely, which may
require additional site- or patient-level data as well as
the ability to risk-adjust performance targets.
One indicator where PCMH designation showed mixed
effects was adherence rates for childhood immunization.
Designated CHCs had comparably lower benchmark proportions and showed no differences in adherence rates
compared to non-designated centers. Whether PCMH
recognition is important for increasing adherence to childhood immunization remains a question that is not well
answered [43]. However, these trends could also reflect
the 2017 changes to HRSA’s immunization indicator,
which now includes all patients who have not seen their
provider before turning age 2 and has increased the numerator to include Hepatitis A, rotavirus, as well as influenza vaccines. While these changes could explain the
decrease in adherence rates from previous years, it does
not explain why adherence rates for immunization targets
remained significantly lower compared to other measures.
However, these findings should be interpreted within
the context of a number of limitations in the data. First,
this study represents a point-in-time cross-sectional
evaluation of clinical performance derived from CHC
performance reports. Although assessments based on
cross-sectional data are limited, they remain the most
widely available option for monitoring changes in care
under the PCMH transition. Attributing differences in
quality to differences in the proportion of recognized delivery sites provides one mechanism to address a longstanding limitation within HRSA’s ongoing PCMH evaluations. A related limitation is the lack of longitudinal
data to measure improvement over time as well as the
lack of data that can be linked back to the delivery site.
Although the findings from this study remain novel, they
do not replace the benefit that access to site-level clinical
reports would bring to these analyses. In absence of
fine-scale data from its delivery sites (e.g., continuity of
care across sites), the proposed methodology serves as
an alternative approach to modeling changes in performance that account for site-level designation.
It is also important to consider these limitations in
light of the geocoding and approximate string-matching
algorithm. Prior to excluding false positive/negative
matches, we were able to confirm 64% of CHCs as having at least one designated delivery site, which was less
than the 77% HRSA published for the same year for the
lower 48 states and District of Columbia [31]. Three factors could have accounted for the observed differences.
One is that we excluded delivery sites whose grantee
was accredited through the AAAHC. In 2018, 48 CHCs
that oversaw 294 delivery sites had obtained AAAHC
accreditation [44]. We excluded the AAAHC database
because it uses a network accreditation process rather
than site-based designation used by the NCQA and JC.
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Although the AAAHC grants all delivery sites a specific
grace period from which to obtain the similar status as a
certified site (e.g., 3 years), it is not possible to determine
which of the CHC’s delivery sites are the accredited
clinics from its reports. This in some ways perpetuates
the limitation embedded in the Commonwealth Survey
and HRSA’s PCMH reports that this study sought to
overcome. Another factor could be that our data linkage
algorithm was too restrictive owing to our emphasis on
avoiding false positives. Another is our lack of access to
archival data, which required that we link data using different time stamps. Finally, our use of non-PCMH centers as controls required that we exclude recognition
time as a potential determinant of care quality, which is
a known factor of PCMH performance.
Despite these limitations, the findings from this study
come at a precarious time when access to high quality
data is urgently needed in order to leverage critical responses to challenges to the impact of COVID-19, particularly within communities that are among the most
socially vulnerable. Without access to data that supports
the patient-centeredness that PCMH designation brings,
we are unlikely to grasp the true significance of COVID19 on long-term changes in population health outcomes.
Harnessing the data linkage and analysis properties of
geographic information systems allows researchers to
overcome some of the limitations in HRSA’s current
data reporting and release statistics and make more robust assessments of patient-centered outcomes for end
users. While the lack of site-level data will remain problematic for fully identifying individual strategies that are
meeting patient needs, the insight that this methodology
affords could make it less difficult to monitor the longterm effect of changes in population health, particularly
those that arise as a result of COVID-19.

Conclusion
One source of variation in previous study findings linking PCMH transformation to improvements in HRSA’s
quality reporting has been the lack of information on the
proportion of CHC delivery sites that are designated
medical homes. A consequence of this limitation is the
inability to generate hypotheses of site-level effects on
overall clinical performance, which some have argued
may be a cause for mixed findings in associations between PCMH designation and performance measures.
The absence of this information impedes efforts to
evaluate whether the medical home program and policy
transitions can be attributed to improvements in patient
care. The methodology proposed in this study provides
an alternative approach to measuring the association between PCMH status and care quality while also accounting for the proportion of a CHC’s delivery sites that are
designated medical homes. The approach has an added
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benefit in that it is based on publicly available information. Our study findings suggest that transformation
does in fact matter, but that it may not appear until a
specific proportion of delivery sites become designated.
There also appears to be a continued stepwise increase
in adherence scores once this threshold is achieved.
Abbreviations
PCMH: Patient-centered medical home; CHC: Community health center;
HRSA: Health resources and service administration; NCQA: National
COMMITTEE FOR QUALITY ASSURANCE; JC: Joint commission; AAAH
C: Accreditation association for ambulatory health care; UDS: Universal data
system
Acknowledgements
Not Applicable.
Authors’ contributions
NB, ALD, RW, and KMS conceptualized the study design. NB and RW
conducted the statistical analysis. NB drafted the initial draft of the article.
All authors discussed the results and implications and commented on the
manuscript at all stages. The author (s) read and approved the final
manuscript.
Funding
The research was not prepared under contract and reflect solely the opinions
and work of the authors.
Availability of data and materials
All locational data used to conduct this study is publicly available and able
to be mapped through linkages with HRSA facilities stored on its GIS server.
A list of currently accredited/recognized NCQA practices can be found at:
https://reportcards.ncqa.org/#/practices/list?recognition=Patient-Centered%2
0Medical%20Home. Joint Commission recognized practices can be found at:
https://www.qualitycheck.org/data-download/. AAAHC sites can be found at:
https://eweb.aaahc.org/eweb/dynamicpage.aspx?site=aaahc_site&webcode=
find_orgs. Readers interested in the SAS code used to build the models
should contact the corresponding author.
Ethics approval and consent to participate
This study was reviewed by the University of South Carolina IRB in
accordance with 45 CFR 46.104(d)(4); the study received an exemption from
Human Research Subject Regulations.
Consent for publication
Not Applicable.
Competing interests
NB is an Associate Editor for BMC Health Services Research. The authors have
no additional competing interests.
Author details
1
College of Nursing, University of South Carolina, Columbia, USA. 2Division of
Integrated Health and Policy Research, Institute for Families in Society,
University of South Carolina, Columbia, USA. 3Division of Integrated Health
and Policy Research, Institute for Families in Society, University of South
Carolina, 1600 Hampton St., Suite 507, Columbia, SC 29208, USA.
Received: 26 May 2020 Accepted: 15 October 2020

References
1. American Academy of Family Physicians, American Academy of Pediatrics,
American College of Physicians, American Osteopathic Association. Joint
principles of the patientcentered medical home 2007 [cited 2020 October
2]; Available from: http://www.aafp.org/dam/AAFP/documents/practice_
management/pcmh/initiatives/PCMHJoint.pdf.
2. U.S. Department of Health and Human Services Centers for Medicare and
Medicaid Services. Health homes for enrollees with chronic conditions. State
Medicaid Director’s Letter 10-024. 2010 [cited 2020 October 20]; Available

Bell et al. BMC Health Services Research

3.

4.
5.
6.

7.

8.

9.
10.

11.
12.
13.

14.

15.

16.

17.
18.

19.

20.

21.
22.
23.

24.

25.

(2020) 20:980

from: http://downloads.cms.gov/cmsgov/archived-downloads/SMDL/
downloads/SMD10024.pdf.
U.S. Department of Health and Human Services Centers for Medicare and
Medicaid Services Center for Medicare and Medicaid Innovation. State
innovation models: Funding for model design and testing assistance. 2012
[cited 2020 October 2]; Available from: http://innovation.cms.gov/Files/x/
StateInnovation_FOA.pdf.
Hoff T, Weller W, DePuccio M. The patient-centered medical home: a review
of recent research. Med Care Res Rev. 2012;69(6):619–44.
Rosenthal TC. The medical home: growing evidence to support a new
approach to primary care. J Am Board Fam Med. 2008;21(5):427–40.
Takach M. Reinventing Medicaid: state innovations to qualify and pay for
patient-centered medical homes show promising results. Health Aff. 2011;
30(7):1325–34.
Harbrecht MG, Latts LM. Colorado's patient-centered medical home pilot
met numerous obstacles, yet saw results such as reduced hospital
admissions. Health Aff (Millwood). 2012;31(9):2010–7.
Patient-Centered Medical Home Collaborative. Defining the Medical Home:
A patient-centered philosophy that drives primary care excellence. 2019
[cited February 28 2019]; Available from: https://www.pcpcc.org/about/
medical-home.
Crimm, A. and D. Liss, Patient-Centered Medical Home Evaluations: Let’s
Keep Them All In Context. 2014: Health Affairs Blog.
National Committee for Quality Assurance. NCQA Report Cards: Patient
Centered Medical Homes. 2017 [cited 2020 October 2]; Available from:
https://reportcards.ncqa.org/#/practices/list?recognition=PatientCentered%20Medical%20Home.
Jackson GL, et al. Patient-centered medical home a systematic review. Ann
Intern Med. 2013;158(3):169.
Peikes D, et al. Early evaluations of the medical home: building on a
promising start. Am J Manag Care. 2012;18(2):105–16.
Sinaiko AD, et al. Synthesis of research on patient-centered medical homes
brings systematic differences into relief. Health Aff (Millwood). 2017;36(3):
500–8.
Basu S, et al. Effects of new funding models for patient-centered medical
homes on primary Care practice finances and services: results of a
microsimulation model. Ann Fam Med. 2016;14(5):404–14.
Rittenhouse DR, et al. Small and medium-size physician practices use few
patient-centered medical home processes. Health Aff (Millwood). 2011;30(8):
1575–84.
Alidina S, et al. Coordination within medical neighborhoods: insights from
the early experiences of Colorado patient-centered medical homes. Health
Care Manag Rev. 2016;41(2):101–12.
Bitton A, Martin C, Landon BE. A nationwide survey of patient centered
medical home demonstration projects. J Gen Intern Med. 2010;25(6):584–92.
Hu R, et al. The Association of Patient-centered Medical Home Designation
with Quality of Care of HRSA-funded Health centers. Med Care. 2018;56:
130–8.
Shippee ND, Finch M, Wholey D. Using statewide data on Health Care
quality to assess the effect of a patient-centered medical home initiative on
quality of Care. Popul Health Manag. 2018;21(2):148–54.
Friedberg MW, et al. Association between participation in a multipayer
medical home intervention and changes in quality, utilization, and costs of
care. JAMA. 2014;311(8):815–25.
Timbie JW, et al. Implementation of medical homes in federally qualified
Health centers. N Engl J Med. 2017;377(3):246–56.
Shi L, et al. Patient-centered medical home capability and clinical
performance in HRSA-supported Health centers. Med Care. 2015;53:389–95.
Beal, A.C., et al. Closing the Divide: How Medical Homes Promote Equity in
Health Care: Results from the Commonwealth Fund 2006 Health Care
Quality Survey. 2007 [cited 2019 February 28]; Available from: https://www.
commonwealthfund.org/publications/fund-reports/2007/jun/closing-dividehow-medical-homes-promote-equity-health-care.
Doty, M.M., et al. Enhancing the Capacity of Community Health Centers to
Achieve High Performance: Findings from the 2009 Commonwealth Fund
National Survey of Federally Qualified Health Centers. 2010 [cited 2019
February 28]; Available from: https://www.commonwealthfund.org/
publications/fund-reports/2010/may/enhancing-capacity-community-healthcenters-achieve-high.
Health Resources & Services Administration. The Affordable Care Act and
Health Centers. 2015 [cited 2019 February 29]; Available from: https://www.

Page 11 of 11

26.

27.

28.

29.

30.

31.

32.

33.

34.
35.

36.
37.

38.

39.

40.

41.
42.
43.
44.

hrsa.gov/sites/default/files/about/news/2012tables/
healthcentersacafactsheet.pdf.
Health Resources & Services Administration. HRSA Accreditation and Patient
Centered Medical Home Recognition Initiative. 2018 [cited 2019 February 29];
Available from: http://bphc.hrsa.gov/policiesregulations/accreditation.html.
Dobbins JM, et al. Patient-centered medical home recognition and diabetes
control among Health centers: exploring the role of enabling services.
Popul Health Manag. 2018;21(1):6–12.
Administration, H.R.S. Defining Scope of Project & Policy for Requesting
Changes. 2020 [cited 2020 October 7]; Available from: https://bphc.hrsa.gov/
programrequirements/policies/pin200801defining.html.
Health Resources & Services Administration. 2018 Health Center Profile:
Health Center Program Grantee Profiles. 2019 [cited 2019 August 26];
Available from: https://bphc.hrsa.gov/uds/datacenter.aspx?q=d.
Rosenthal, M.B., et al. Recommended Core Measures for Evaluating the
Patient-Centered Medical Home: Cost, Utilization, and Clinical Quality. 2012
[cited February 21 2019]; Available from: https://www.commonwealthfund.
org/sites/default/files/documents/___media_files_publications_data_brief_2
012_1601_rosenthal_recommended_core_measures_pcmh_v2.pdf.
Health Resources & Services Administration. Health Center Quality
Improvement FY 2018 Grant Awards (August 2018). 2018 [cited 2019
September 10]; Available from: https://bphc.hrsa.gov/sites/default/files/
bphc/datareporting/reporting/fy-18-qia-ta-webinar_0.pdf.
Rhodes KV, et al. Pennsylvania's medical home initiative: reductions in
healthcare utilization and cost among Medicaid patients with Medicaland
psychiatric comorbidities. J Gen Intern Med. 2016;31(11):1373–81.
van Hasselt M, et al. Total cost of care lower among Medicare fee-forservice beneficiaries receiving care from patient-centered medical homes.
Health Serv Res. 2015;50(1):253–72.
Bergert L, et al. Linking patient-centered medical home and asthma measures
reduces hospital readmission rates. Pediatrics. 2014;134(1):e249–56.
Carew AP, Resnick B. Outcomes of the Maryland person-centered hospital
discharge program: a pilot targeting decreasing long-term care use and
hospital readmissions. Care Manage J. 2015;16(1):48–58.
Farrell TW, et al. Impact of an integrated transition management program in
primary care on hospital readmissions. J Healthc Qual. 2015;37(1):81–92.
Matthews WA. Care coordination measures of a family medicine residency
as a model for hospital readmission reduction. Am J Manag Care. 2014;
20(11):e532–4.
Stranges PM, et al. A multidisciplinary intervention for reducing
readmissions among older adults in a patient-centered medical home. Am J
Manag Care. 2015;21(2):106–13.
Markovitz AR, et al. Patient-centered medical home implementation and
use of preventive services: the role of practice socioeconomic context.
JAMA Intern Med. 2015;175(4):598–606.
Frost, J.J., et al. Publicly Funded Contraceptive Services At U.S. Clinics, 2015.
2017 [cited 2019 October 17]; Available from: https://www.guttmacher.org/
sites/default/files/report_pdf/publicly_funded_contraceptive_services_2
015_3.pdf.
Twiddy, D., Practice Transformation: Lessons From a Safety Net Clinic. Family
practice management, 2014. March–April.
Shi L, Singh DA. Delivering Health Care in America: A Systems Approach.
6th ed. Sudbury, MA: Ones And Bartlett Publishers; 2015.
Samuels RC, et al. Immunizations in children with special health care needs
in a medical home model of care. Matern Child Health J. 2008;12(3):357–62.
Accreditation Association for Ambulatory Health Care. Find a Health Care
Organization. 2019 [cited 2019 February 21]; Available from: https://eweb.
aaahc.org/eWeb/DynamicPage.aspx? Site=aaahc_site&WebKey=94f04d3962b7-45ba-9b21-98de165b328a&FromSearchControl=
yes&FromSearchControl=Yes.

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.

